×

Methods of treatment using anti-ERBB antibody-maytansinoid conjugates

CAFC
  • US 8,337,856 B2
  • Filed: 12/03/2007
  • Issued: 12/25/2012
  • Est. Priority Date: 03/16/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. An immunoconjugate comprising an anti-ErbB2 antibody conjugated to a maytansinoid, wherein the antibody is huMAb4D5-8.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×